ctrl K

Watchlist Price Alert

MiNK Therapeutics Inc. (INKT)

NASDAQ: INKT · Real-Time Price · USD

7.35

-0.22 (-2.94%)

At close: Jun 17, 2025, 12:49 PM

MiNK Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	2.7B	n/a	n/a	689.63K
Cost of Revenue	215.44K	204.62K	30.95B	28.36B	55.06K	n/a
Gross Profit	n/a	-204.62K	-28.24B	-28.36B	-55.06K	689.63K
Operating Income	-10.65M	-22.92M	-30.95M	-28.36M	-14.64M	-22.28M
Interest Income	n/a	463.26K	253.32K	2.43K	2.44K	1.56K
Pretax Income	-10.78M	-22.46M	-27.99M	-30.21M	-16.24M	-23.8M
Net Income	-10.78M	-22.46M	-24.78M	-23.11M	-15.68M	-25.91M
Selling & General & Admin	4.1M	7.43M	7.83M	4.64M	1.29M	3.83M
Research & Development	6.34M	15.49M	23.12M	13.97M	9.51M	19.65M
Other Expenses	n/a	-0.00	2.7M	-9.53M	-3M	551.24K
Operating Expenses	10.43M	22.72M	30.95M	18.61M	10.8M	23.48M
Interest Expense	n/a	n/a	253.32K	2.43M	2.44M	1.56M
Selling & Marketing Expenses	-4.31B	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	22.92M	30.95M	18.61M	10.8M	23.48M
Income Tax Expense	-10.77B	n/a	-3.21M	-7.1M	-560.38K	2.11M
Shares Outstanding (Basic)	3.77M	34.36M	33.67M	33.48M	33.09M	33.09M
Shares Outstanding (Diluted)	3.77M	34.36M	33.67M	33.48M	33.09M	33.09M
EPS (Basic)	-285.82	-0.65	-0.74	-0.69	-0.47	-0.78
EPS (Diluted)	-285.82	-0.65	-0.74	-0.69	-0.47	-0.78
EBITDA	-10.57M	-22.25M	-30.83M	-27.7M	-13.74M	-22.2M
EBIT	-10.78M	-22.46M	-30.95M	-27.78M	-13.8M	-22.24M
Depreciation & Amortization	215.44K	204.62K	121.75K	77.96K	55.06K	36.82K